Cardiovascular disease (CVD) is the leading cause of death worldwide. Due to limited regenerative capacity adult heart, treatments based on human pluripotent stem cells (hPSCs) have become focus a great deal research. Human cell–derived cardiomyocytes (hPSC-CMs) can provide an ideal cell source for CVD model construction, cardiac tissue repair, and drug cardiotoxicology However, immaturity hPSC...